Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY518674 and Atorvastatin in Hypercholesterolemia
NCT00133380Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jul 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ly518674 in hypercholesterolemia, sponsored by Eli Lilly and Company. Started Jul 2005; status: completed.
02
Drugs
ly518674
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00133380.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00133380.